Welcome to The Visible Embryo
  o
Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform


The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!





Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

 

Pregnancy Timeline by SemestersLungs begin to produce surfactantImmune system beginningHead may position into pelvisFull TermPeriod of rapid brain growthWhite fat begins to be madeHead may position into pelvisWhite fat begins to be madeImmune system beginningBrain convolutions beginBrain convolutions beginFetal liver is producing blood cellsSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007
 
 

Home | Pregnancy Timeline | News Alerts |News Archive Apr 23, 2015

These new stem cells can help treat skull malformation in infants - craniosynostosis,
and is encouraging as a potential treatment for all skull deformities.
Image Credit: TheArtistOfLife.com

 

 






 

 

Stem cells prevent birth defect - repair facial bones

Researchers have pinpointed the primary cause of a rare skull disorder in infants, a discovery that could also help wounded soldiers, car-wreck victims and other patients recover from disfiguring facial injuries.


"This has a more implications than we initially thought. We can take advantage of these stem cells not only to repair a birth defect, but to provide facial regeneration for veterans or other people who have suffered traumatic injury."

Yang Chai PhD, lead researcher, the Herman Ostrow School of Dentistry, University of Southern California.


Chai predicted such treatment could be available to patients within the next five to 10 years, providing it shows promise in clinical trials with patients.

"It is a very minimal procedure to just cut off a strip of bone instead of cutting the entire calvaria [skull cap]," Chai added. A stem cell treatment "will truly restore the normal anatomy, which will then be able to respond to the continuous brain growth and the patient can live a normal life."

The team's findings have shifted the scientific perspective on bone disease, according to Hu Zhao, who conducted most of the study's tests on mice.


"Before our findings, people assumed bones all around the body are the same. We are now showing that they are all totally different; that they have a different source of stem cells and a different healing mechanism."

Hu Zhao PhD, Center for Craniofacial Molecular Biology, Ostrow School of Dentistry, University of Southern California.


In their study, the team tracked Gli1+ stem cells that appear within tissues connecting craniofacial bones. They found that a shortage of Gli1+ stem cells hardened the skull and fused the sutures, causing "craniosynostosis," a birth defect that can hinder brain development. So they became curious as to whether Gli1+ stem cells can serve another purpose. They then transplanted the Gli1+ stem cells into injured skull bone areas of mice and within weeks, noticed Gli1+ stem cells were migrating on their own to injured skull areas.

Chai believes the discovery that Gli1+ stem cells assist in bone regeneration indicates doctors will be able to help people who have suffered disfiguring facial injuries in addition to infants diagnosed with craniosynostosis. Using biological treatments instead of multiple high-risk surgeries would be a significant improvement in the quality of life for patients needing help.

Until now, surgeons had unknowingly destroyed regenerative stem cells when operating on craniosynostosis patients. During a typical surgery, doctors break the skull apart to allow for the brain to grow more. Doctors then staple remaining pieces back together and discard unused or damaged bone tissue as waste. However, Gli1+ stem cells are activatied during injury repair. Zhao believes such a procedure actually interferres with healing as Gli1+ stem cells could be lost on the removed bone.

A biological approach would transplant Gli1+ stem cells into targeted areas of skull damage, particularly in infants with craniosynostosis. Growing skull bone would give infants the flexibility needed for their brains to continue to grow normally. For other patients who have suffered head trauma or facial disfigurement due to cancers, the Gli+1 stem cells could help repair fractured or eroded skull areas.

Researchers plan to conduct additional laboratory experiments before the treatment is tested in clinical trials with patients.

The findings were published in this month's issue of the journal Nature Cell Biology.

Abstract
Bone tissue undergoes constant turnover supported by stem cells. Recent studies showed that perivascular mesenchymal stem cells (MSCs) contribute to the turnover of long bones. Craniofacial bones are flat bones derived from a different embryonic origin than the long bones. The identity and regulating niche for craniofacial-bone MSCs remain unknown. Here, we identify ?Gli1+ cells within the suture mesenchyme as the main MSC population for craniofacial bones. They are not associated with vasculature, give rise to all craniofacial bones in the adult and are activated during injury repair. ?Gli1+ cells are typical MSCs in vitro. Ablation of ?Gli1+ cells leads to craniosynostosis and arrest of skull growth, indicating that these cells are an indispensable stem cell population. ?Twist1+/− mice with craniosynostosis show reduced ?Gli1+ MSCs in sutures, suggesting that craniosynostosis may result from diminished suture stem cells. Our study indicates that craniofacial sutures provide a unique niche for MSCs for craniofacial bone homeostasis and repair.

The study was supported by grants to Chai from the National Institute of Dental and Craniofacial Research at the National Institutes of Health.

Return to top of page